Global Peripheral Intervention Drug-Eluting Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Peripheral Intervention Drug-Eluting Devices market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Peripheral Intervention Drug-Eluting Devices industry chain, the market status of Plain Old Balloon Angioplasty (POBA) (Drug-Eluting Balloons, Drug-Eluting Stents), Percutaneous Transluminal Angioplasty (PTA) (Drug-Eluting Balloons, Drug-Eluting Stents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peripheral Intervention Drug-Eluting Devices.
Regionally, the report analyzes the Peripheral Intervention Drug-Eluting Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peripheral Intervention Drug-Eluting Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Peripheral Intervention Drug-Eluting Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peripheral Intervention Drug-Eluting Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Drug-Eluting Balloons, Drug-Eluting Stents).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peripheral Intervention Drug-Eluting Devices market.
Regional Analysis: The report involves examining the Peripheral Intervention Drug-Eluting Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peripheral Intervention Drug-Eluting Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Peripheral Intervention Drug-Eluting Devices:
Company Analysis: Report covers individual Peripheral Intervention Drug-Eluting Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peripheral Intervention Drug-Eluting Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Plain Old Balloon Angioplasty (POBA), Percutaneous Transluminal Angioplasty (PTA)).
Technology Analysis: Report covers specific technologies relevant to Peripheral Intervention Drug-Eluting Devices. It assesses the current state, advancements, and potential future developments in Peripheral Intervention Drug-Eluting Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peripheral Intervention Drug-Eluting Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Peripheral Intervention Drug-Eluting Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peripheral Intervention Drug-Eluting Devices, with price, sales, revenue and global market share of Peripheral Intervention Drug-Eluting Devices from 2019 to 2024.
Chapter 3, the Peripheral Intervention Drug-Eluting Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Intervention Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Peripheral Intervention Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peripheral Intervention Drug-Eluting Devices.
Chapter 14 and 15, to describe Peripheral Intervention Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Peripheral Intervention Drug-Eluting Devices industry chain, the market status of Plain Old Balloon Angioplasty (POBA) (Drug-Eluting Balloons, Drug-Eluting Stents), Percutaneous Transluminal Angioplasty (PTA) (Drug-Eluting Balloons, Drug-Eluting Stents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peripheral Intervention Drug-Eluting Devices.
Regionally, the report analyzes the Peripheral Intervention Drug-Eluting Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peripheral Intervention Drug-Eluting Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Peripheral Intervention Drug-Eluting Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peripheral Intervention Drug-Eluting Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Drug-Eluting Balloons, Drug-Eluting Stents).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peripheral Intervention Drug-Eluting Devices market.
Regional Analysis: The report involves examining the Peripheral Intervention Drug-Eluting Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peripheral Intervention Drug-Eluting Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Peripheral Intervention Drug-Eluting Devices:
Company Analysis: Report covers individual Peripheral Intervention Drug-Eluting Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peripheral Intervention Drug-Eluting Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Plain Old Balloon Angioplasty (POBA), Percutaneous Transluminal Angioplasty (PTA)).
Technology Analysis: Report covers specific technologies relevant to Peripheral Intervention Drug-Eluting Devices. It assesses the current state, advancements, and potential future developments in Peripheral Intervention Drug-Eluting Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peripheral Intervention Drug-Eluting Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Peripheral Intervention Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Drug-Eluting Balloons
- Drug-Eluting Stents
- Plain Old Balloon Angioplasty (POBA)
- Percutaneous Transluminal Angioplasty (PTA)
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cardinal Health
- B. Braun Melsungen AG
- Biosensors International Group Ltd.
- C.R. Bard, Inc.
- Abbott
- The Lubrizol Corporation
- Terumo Corporation
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Peripheral Intervention Drug-Eluting Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peripheral Intervention Drug-Eluting Devices, with price, sales, revenue and global market share of Peripheral Intervention Drug-Eluting Devices from 2019 to 2024.
Chapter 3, the Peripheral Intervention Drug-Eluting Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Intervention Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Peripheral Intervention Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peripheral Intervention Drug-Eluting Devices.
Chapter 14 and 15, to describe Peripheral Intervention Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Market Analysis by Application
1.4.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Plain Old Balloon Angioplasty (POBA)
1.4.3 Percutaneous Transluminal Angioplasty (PTA)
1.5 Global Peripheral Intervention Drug-Eluting Devices Market Size & Forecast
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity (2019-2030)
1.5.3 Global Peripheral Intervention Drug-Eluting Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Medtronic plc
2.1.1 Medtronic plc Details
2.1.2 Medtronic plc Major Business
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
2.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic plc Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
2.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 Cardinal Health
2.4.1 Cardinal Health Details
2.4.2 Cardinal Health Major Business
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
2.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cardinal Health Recent Developments/Updates
2.5 B. Braun Melsungen AG
2.5.1 B. Braun Melsungen AG Details
2.5.2 B. Braun Melsungen AG Major Business
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
2.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 B. Braun Melsungen AG Recent Developments/Updates
2.6 Biosensors International Group Ltd.
2.6.1 Biosensors International Group Ltd. Details
2.6.2 Biosensors International Group Ltd. Major Business
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
2.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biosensors International Group Ltd. Recent Developments/Updates
2.7 C.R. Bard, Inc.
2.7.1 C.R. Bard, Inc. Details
2.7.2 C.R. Bard, Inc. Major Business
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
2.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 C.R. Bard, Inc. Recent Developments/Updates
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
2.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Abbott Recent Developments/Updates
2.9 The Lubrizol Corporation
2.9.1 The Lubrizol Corporation Details
2.9.2 The Lubrizol Corporation Major Business
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 The Lubrizol Corporation Recent Developments/Updates
2.10 Terumo Corporation
2.10.1 Terumo Corporation Details
2.10.2 Terumo Corporation Major Business
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Terumo Corporation Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY MANUFACTURER
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2024)
3.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Peripheral Intervention Drug-Eluting Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2023
3.5 Peripheral Intervention Drug-Eluting Devices Market: Overall Company Footprint Analysis
3.5.1 Peripheral Intervention Drug-Eluting Devices Market: Region Footprint
3.5.2 Peripheral Intervention Drug-Eluting Devices Market: Company Product Type Footprint
3.5.3 Peripheral Intervention Drug-Eluting Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2030)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2019-2030)
4.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.5 South America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
5.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2019-2030)
5.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
6.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2019-2030)
6.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
7.2 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
7.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
7.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
8.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
8.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
8.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
10.2 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
10.3 South America Peripheral Intervention Drug-Eluting Devices Market Size by Country
10.3.1 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Peripheral Intervention Drug-Eluting Devices Market Drivers
12.2 Peripheral Intervention Drug-Eluting Devices Market Restraints
12.3 Peripheral Intervention Drug-Eluting Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Peripheral Intervention Drug-Eluting Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Peripheral Intervention Drug-Eluting Devices
13.3 Peripheral Intervention Drug-Eluting Devices Production Process
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Peripheral Intervention Drug-Eluting Devices Typical Distributors
14.3 Peripheral Intervention Drug-Eluting Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Market Analysis by Application
1.4.1 Overview: Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Plain Old Balloon Angioplasty (POBA)
1.4.3 Percutaneous Transluminal Angioplasty (PTA)
1.5 Global Peripheral Intervention Drug-Eluting Devices Market Size & Forecast
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity (2019-2030)
1.5.3 Global Peripheral Intervention Drug-Eluting Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Medtronic plc
2.1.1 Medtronic plc Details
2.1.2 Medtronic plc Major Business
2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
2.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic plc Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
2.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 Cardinal Health
2.4.1 Cardinal Health Details
2.4.2 Cardinal Health Major Business
2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
2.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cardinal Health Recent Developments/Updates
2.5 B. Braun Melsungen AG
2.5.1 B. Braun Melsungen AG Details
2.5.2 B. Braun Melsungen AG Major Business
2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
2.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 B. Braun Melsungen AG Recent Developments/Updates
2.6 Biosensors International Group Ltd.
2.6.1 Biosensors International Group Ltd. Details
2.6.2 Biosensors International Group Ltd. Major Business
2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
2.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biosensors International Group Ltd. Recent Developments/Updates
2.7 C.R. Bard, Inc.
2.7.1 C.R. Bard, Inc. Details
2.7.2 C.R. Bard, Inc. Major Business
2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
2.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 C.R. Bard, Inc. Recent Developments/Updates
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
2.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Abbott Recent Developments/Updates
2.9 The Lubrizol Corporation
2.9.1 The Lubrizol Corporation Details
2.9.2 The Lubrizol Corporation Major Business
2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 The Lubrizol Corporation Recent Developments/Updates
2.10 Terumo Corporation
2.10.1 Terumo Corporation Details
2.10.2 Terumo Corporation Major Business
2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
2.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Terumo Corporation Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY MANUFACTURER
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2024)
3.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Peripheral Intervention Drug-Eluting Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2023
3.5 Peripheral Intervention Drug-Eluting Devices Market: Overall Company Footprint Analysis
3.5.1 Peripheral Intervention Drug-Eluting Devices Market: Region Footprint
3.5.2 Peripheral Intervention Drug-Eluting Devices Market: Company Product Type Footprint
3.5.3 Peripheral Intervention Drug-Eluting Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2030)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2019-2030)
4.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.5 South America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
5.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2019-2030)
5.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
6.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2019-2030)
6.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
7.2 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
7.3 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country
7.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
8.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
8.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
8.3.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
10.2 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
10.3 South America Peripheral Intervention Drug-Eluting Devices Market Size by Country
10.3.1 South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Peripheral Intervention Drug-Eluting Devices Market Drivers
12.2 Peripheral Intervention Drug-Eluting Devices Market Restraints
12.3 Peripheral Intervention Drug-Eluting Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Peripheral Intervention Drug-Eluting Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Peripheral Intervention Drug-Eluting Devices
13.3 Peripheral Intervention Drug-Eluting Devices Production Process
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Peripheral Intervention Drug-Eluting Devices Typical Distributors
14.3 Peripheral Intervention Drug-Eluting Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic plc Major Business
Table 5. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
Table 6. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Medtronic plc Recent Developments/Updates
Table 8. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Corporation Major Business
Table 10. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 11. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Boston Scientific Corporation Recent Developments/Updates
Table 13. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Laboratories Major Business
Table 15. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
Table 16. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Laboratories Recent Developments/Updates
Table 18. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 19. Cardinal Health Major Business
Table 20. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
Table 21. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Cardinal Health Recent Developments/Updates
Table 23. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen AG Major Business
Table 25. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
Table 26. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. B. Braun Melsungen AG Recent Developments/Updates
Table 28. Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Biosensors International Group Ltd. Major Business
Table 30. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 31. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Biosensors International Group Ltd. Recent Developments/Updates
Table 33. C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. C.R. Bard, Inc. Major Business
Table 35. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 36. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. C.R. Bard, Inc. Recent Developments/Updates
Table 38. Abbott Basic Information, Manufacturing Base and Competitors
Table 39. Abbott Major Business
Table 40. Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
Table 41. Abbott Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Abbott Recent Developments/Updates
Table 43. The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors
Table 44. The Lubrizol Corporation Major Business
Table 45. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 46. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. The Lubrizol Corporation Recent Developments/Updates
Table 48. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Terumo Corporation Major Business
Table 50. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 51. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Terumo Corporation Recent Developments/Updates
Table 53. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Peripheral Intervention Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Peripheral Intervention Drug-Eluting Devices Production Site of Key Manufacturer
Table 58. Peripheral Intervention Drug-Eluting Devices Market: Company Product Type Footprint
Table 59. Peripheral Intervention Drug-Eluting Devices Market: Company Product Application Footprint
Table 60. Peripheral Intervention Drug-Eluting Devices New Market Entrants and Barriers to Market Entry
Table 61. Peripheral Intervention Drug-Eluting Devices Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Peripheral Intervention Drug-Eluting Devices Raw Material
Table 121. Key Manufacturers of Peripheral Intervention Drug-Eluting Devices Raw Materials
Table 122. Peripheral Intervention Drug-Eluting Devices Typical Distributors
Table 123. Peripheral Intervention Drug-Eluting Devices Typical Customers
Table 1. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic plc Major Business
Table 5. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product and Services
Table 6. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Medtronic plc Recent Developments/Updates
Table 8. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Corporation Major Business
Table 10. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 11. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Boston Scientific Corporation Recent Developments/Updates
Table 13. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Laboratories Major Business
Table 15. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product and Services
Table 16. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Laboratories Recent Developments/Updates
Table 18. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 19. Cardinal Health Major Business
Table 20. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product and Services
Table 21. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Cardinal Health Recent Developments/Updates
Table 23. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen AG Major Business
Table 25. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product and Services
Table 26. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. B. Braun Melsungen AG Recent Developments/Updates
Table 28. Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Biosensors International Group Ltd. Major Business
Table 30. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 31. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Biosensors International Group Ltd. Recent Developments/Updates
Table 33. C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. C.R. Bard, Inc. Major Business
Table 35. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product and Services
Table 36. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. C.R. Bard, Inc. Recent Developments/Updates
Table 38. Abbott Basic Information, Manufacturing Base and Competitors
Table 39. Abbott Major Business
Table 40. Abbott Peripheral Intervention Drug-Eluting Devices Product and Services
Table 41. Abbott Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Abbott Recent Developments/Updates
Table 43. The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors
Table 44. The Lubrizol Corporation Major Business
Table 45. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 46. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. The Lubrizol Corporation Recent Developments/Updates
Table 48. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Terumo Corporation Major Business
Table 50. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product and Services
Table 51. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Terumo Corporation Recent Developments/Updates
Table 53. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Peripheral Intervention Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Peripheral Intervention Drug-Eluting Devices Production Site of Key Manufacturer
Table 58. Peripheral Intervention Drug-Eluting Devices Market: Company Product Type Footprint
Table 59. Peripheral Intervention Drug-Eluting Devices Market: Company Product Application Footprint
Table 60. Peripheral Intervention Drug-Eluting Devices New Market Entrants and Barriers to Market Entry
Table 61. Peripheral Intervention Drug-Eluting Devices Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Peripheral Intervention Drug-Eluting Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Peripheral Intervention Drug-Eluting Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Peripheral Intervention Drug-Eluting Devices Raw Material
Table 121. Key Manufacturers of Peripheral Intervention Drug-Eluting Devices Raw Materials
Table 122. Peripheral Intervention Drug-Eluting Devices Typical Distributors
Table 123. Peripheral Intervention Drug-Eluting Devices Typical Customers
LIST OF FIGURES
Figure 1. Peripheral Intervention Drug-Eluting Devices Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Type in 2023
Figure 4. Drug-Eluting Balloons Examples
Figure 5. Drug-Eluting Stents Examples
Figure 6. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Application in 2023
Figure 8. Plain Old Balloon Angioplasty (POBA) Examples
Figure 9. Percutaneous Transluminal Angioplasty (PTA) Examples
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Peripheral Intervention Drug-Eluting Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 52. China Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Peripheral Intervention Drug-Eluting Devices Market Drivers
Figure 73. Peripheral Intervention Drug-Eluting Devices Market Restraints
Figure 74. Peripheral Intervention Drug-Eluting Devices Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices in 2023
Figure 77. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 78. Peripheral Intervention Drug-Eluting Devices Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Peripheral Intervention Drug-Eluting Devices Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Type in 2023
Figure 4. Drug-Eluting Balloons Examples
Figure 5. Drug-Eluting Stents Examples
Figure 6. Global Peripheral Intervention Drug-Eluting Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Application in 2023
Figure 8. Plain Old Balloon Angioplasty (POBA) Examples
Figure 9. Percutaneous Transluminal Angioplasty (PTA) Examples
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Peripheral Intervention Drug-Eluting Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Peripheral Intervention Drug-Eluting Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Peripheral Intervention Drug-Eluting Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 52. China Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Peripheral Intervention Drug-Eluting Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Peripheral Intervention Drug-Eluting Devices Market Drivers
Figure 73. Peripheral Intervention Drug-Eluting Devices Market Restraints
Figure 74. Peripheral Intervention Drug-Eluting Devices Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Peripheral Intervention Drug-Eluting Devices in 2023
Figure 77. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 78. Peripheral Intervention Drug-Eluting Devices Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
